Willems Luc
Cellular and Molecular Biology, Agro-Bio Tech (FUSAG), Gembloux, Belgium.
Retrovirology. 2009 Aug 17;6:77. doi: 10.1186/1742-4690-6-77.
The "14th International Conference on Human Retrovirology: HTLV and Related Retroviruses" was held in Salvador, Bahia, from July 1st to July 4th 2009. The aim of this biennial meeting is to promote discussion and share new findings between researchers and clinicians for the benefit of patients infected by human T-lymphotropic virus (HTLV). HTLV infects approximately 15-20 million individuals worldwide and causes a broad spectrum of diseases including neurodegeneration and leukemia. The scientific program included a breadth of HTLV research topics: epidemiology, host immune response, basic mechanisms of protein function, virology, pathogenesis, clinical aspects and treatment. Exciting new findings were presented in these different fields, and the new advances have led to novel clinical trials. Here, highlights from this conference are summarized.
“第14届人类逆转录病毒学国际会议:HTLV及相关逆转录病毒”于2009年7月1日至4日在巴伊亚州萨尔瓦多举行。本次两年一度会议的目的是促进研究人员和临床医生之间的讨论并分享新发现,以造福于感染人类嗜T淋巴细胞病毒(HTLV)的患者。HTLV在全球感染了约1500万至2000万人,并导致包括神经退行性变和白血病在内的多种疾病。科学议程涵盖了广泛的HTLV研究主题:流行病学、宿主免疫反应、蛋白质功能的基本机制、病毒学、发病机制、临床方面及治疗。在这些不同领域展示了令人兴奋的新发现,这些新进展已促成新的临床试验。在此,对本次会议的亮点进行总结。